|
Volumn 143, Issue 2, 2007, Pages 335-338
|
Anti-VEGF Bevacizumab (Avastin®) for Radiation Optic Neuropathy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BEVACIZUMAB;
ABSENCE OF SIDE EFFECTS;
AGED;
ANGIOGRAPHY;
ARTICLE;
CASE REPORT;
DRUG TOLERABILITY;
EYE PHOTOGRAPHY;
FEMALE;
FOLLOW UP;
HUMAN;
INTERVENTION STUDY;
INTRAOCULAR HEMORRHAGE;
OPHTHALMOSCOPY;
OPTIC DISK;
OPTIC NERVE;
OPTIC NERVE LESION;
OPTICAL COHERENCE TOMOGRAPHY;
OUTCOME ASSESSMENT;
PAPILLEDEMA;
PRIORITY JOURNAL;
RADIATION OPTIC NEUROPATHY;
RADIATION SICKNESS;
SCANNING LASER OPHTHALMOSCOPY;
SYMPTOM;
VISION;
VISUAL ACUITY;
VISUAL IMPAIRMENT;
AGED;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL;
BRACHYTHERAPY;
CHOROID NEOPLASMS;
FEMALE;
FLUORESCEIN ANGIOGRAPHY;
HUMANS;
INJECTIONS;
MELANOMA;
OPHTHALMOSCOPY;
OPTIC DISK;
OPTIC NERVE DISEASES;
RADIATION INJURIES;
TOMOGRAPHY, OPTICAL COHERENCE;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VISUAL ACUITY;
VITREOUS BODY;
|
EID: 33846362539
PISSN: 00029394
EISSN: None
Source Type: Journal
DOI: 10.1016/j.ajo.2006.09.014 Document Type: Article |
Times cited : (86)
|
References (5)
|